Joel Morganroth
Directeur/Membre du Conseil chez ACR Image Metrix
Profil
Joel Morganroth is currently a Director at ACR Image Metrix and Eleison Pharmaceuticals, Inc. He was previously the President, Chief Executive Officer & Director at ERT Operating Co. from 1997 to 1999.
He also worked as a Clinical Professor-Medicine at Perelman School of Medicine.
Dr. Morganroth received his undergraduate and doctorate degrees from the University of Michigan in 1966 and 1970, respectively.
Postes actifs de Joel Morganroth
Sociétés | Poste | Début |
---|---|---|
ACR Image Metrix | Directeur/Membre du Conseil | 27/10/2011 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Joel Morganroth
Sociétés | Poste | Fin |
---|---|---|
Perelman School of Medicine | Corporate Officer/Principal | - |
ERT Operating Co.
ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA. | Directeur Général | 30/04/2011 |
Formation de Joel Morganroth
University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
ERT Operating Co.
ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA. | Commercial Services |
ACR Image Metrix | |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |